These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8742558)

  • 21. Factor structure and diagnostic efficiency of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for avoidant personality disorder in Hispanic men and women with substance use disorders.
    Becker DF; Añez LM; Paris M; Bedregal L; Grilo CM
    Compr Psychiatry; 2009; 50(5):463-70. PubMed ID: 19683617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target populations and interventions in prevention research: what is high risk?
    Pentz MA
    NIDA Res Monogr; 1994; 139():75-93. PubMed ID: 8742552
    [No Abstract]   [Full Text] [Related]  

  • 23. Methodological concerns for non-Hispanic investigators conducting research with Hispanic Americans.
    Lange JW
    Res Nurs Health; 2002 Oct; 25(5):411-9. PubMed ID: 12221694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilizing dissemination findings to help understand and bridge the research and practice gap in the treatment of substance abuse disorders in Hispanic populations.
    Santisteban D; Vega RR; Suarez-Morales L
    Drug Alcohol Depend; 2006 Sep; 84 Suppl 1():S94-101. PubMed ID: 16828985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-year study of patterns and predictors of substance use among Mexican American youth.
    Zapata JT; Katims DS; Yin Z
    Adolescence; 1998; 33(130):391-403. PubMed ID: 9706325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving drug treatment services for Hispanics: research gaps and scientific opportunities.
    Alegría M; Page JB; Hansen H; Cauce AM; Robles R; Blanco C; Cortes DE; Amaro H; Morales A; Berry P
    Drug Alcohol Depend; 2006 Sep; 84 Suppl 1():S76-84. PubMed ID: 16781087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia.
    Beyers JM; Toumbourou JW; Catalano RF; Arthur MW; Hawkins JD
    J Adolesc Health; 2004 Jul; 35(1):3-16. PubMed ID: 15193569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flour from another sack. Understanding culture is key to treating Hispanic immigrant patients.
    Carlson RP
    Tex Med; 1996 Oct; 92(10):36-43. PubMed ID: 8923771
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV outreach and substance abuse treatment for Latino drug users: Implications for program planning.
    Lundgren LM; Delgado M
    Eval Program Plann; 2008 Feb; 31(1):61-3. PubMed ID: 18222141
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug and alcohol use among rural Mexican-Americans.
    Castro FG; Gutierres S
    NIDA Res Monogr; 1997; 168():498-530. PubMed ID: 9260179
    [No Abstract]   [Full Text] [Related]  

  • 31. Methodological issues in the assessment of substance use phenotypes.
    Neale MC; Aggen SH; Maes HH; Kubarych TS; Schmitt JE
    Addict Behav; 2006 Jun; 31(6):1010-34. PubMed ID: 16723188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low birthweight among US Hispanic/Latino subgroups: the effect of maternal foreign-born status and education.
    Acevedo-Garcia D; Soobader MJ; Berkman LF
    Soc Sci Med; 2007 Dec; 65(12):2503-16. PubMed ID: 17764796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey.
    Crespo CJ; Loria CM; Burt VL
    Public Health Rep; 1996; 111 Suppl 2(Suppl 2):7-10. PubMed ID: 8898761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling of intervention effects.
    Bentler PM
    NIDA Res Monogr; 1991; 107():159-82. PubMed ID: 1922304
    [No Abstract]   [Full Text] [Related]  

  • 35. Hispanic subgroups and intraracial comparisons.
    Wong FY; McKay DR
    Am J Public Health; 1992 Dec; 82(12):1691. PubMed ID: 1456351
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessing effectiveness of drug abuse prevention: implementation issues relevant to long-term effects and replication.
    Hawkins JD; Abbott R; Catalano RF; Gillmore MR
    NIDA Res Monogr; 1991; 107():195-212. PubMed ID: 1922306
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcome measurement issues in drug abuse prevention studies.
    Dwyer JH; MacKinnon DP
    NIDA Res Monogr; 1991; 107():183-94. PubMed ID: 1922305
    [No Abstract]   [Full Text] [Related]  

  • 38. Issues in drug abuse prevention intervention research with African Americans.
    Beatty LA
    NIDA Res Monogr; 1994; 139():171-201. PubMed ID: 8742557
    [No Abstract]   [Full Text] [Related]  

  • 39. Qualitative methodological issues in drug user research.
    Valdez A; Sifaneck SJ
    Subst Use Misuse; 2010 Apr; 45(5):645-7. PubMed ID: 20222776
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental and quasi-experimental designs in prevention research.
    Snow DL; Tebes JK
    NIDA Res Monogr; 1991; 107():140-58. PubMed ID: 1922303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.